Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Sastre, J; de la Orden, V; Martinez, A; Bando, I; Balbin, M; Bellosillo, B; Palanca, S; Gomez, MIP; Mediero, B; Llovet, P; Moral, VM; Vieitez, JM; Garcia-Alfonso, P; Calle, SG; Ortiz-Morales, MJ; Salud, A; Quintero, G; Lopez, C; Diaz-Rubio, E; Aranda, E.

Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naive Metastatic Colorectal Cancer Patients Prospectively Collected

CLINICAL COLORECTAL CANCER. 2020; 19(3): 110-116 Nº de citas: 26 [doi:10.1016/j.clcc.2020.02.014]

Martin, M; Guerrero-Zotano, A; Montero, A; Jara, C; Filipovich, E; Rojo, F; Moreno, F; Garcia-Saenz, JA; Ales, JE; Chacon, JI; Cruz, J; Gimenez, J; Cruz-Merino, L; Algara, M; Santisteban, M; Tarruella, SL.

GEICAMGuidelines for the Management of Patients with Breast Cancer During theCOVID-19 Pandemic in Spain

ONCOLOGIST. 2020; 25(9): 1339-1345 Nº de citas: 11 [doi:10.1634/theoncologist.2020-0363]

Moran, T; Taus, A; Arriola, E; Aguado, C; Domine, M; Rueda, AG; Calles, A; Cedres, S; Vinolas, N; Isla, D; Palmero, R; Sereno, M; Diaz, V; Juan, O; Marse, R; Martorell, PM; Torres, JMS; Uncommon EGFR Mutations Spain.

Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study

CLINICAL LUNG CANCER. 2020; 21(5): 428 Nº de citas: 15 [doi:10.1016/j.cllc.2020.04.011]

Aviles-Izquierdo, JA; Nieto-Benito, LM; Lazaro-Ochaita, P; Escat-Cortes, JL; Marquez-Rodas, I; Mercader-Cidoncha, E.

Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(9): 1611-1618 [doi:10.1007/s12094-020-02306-w]

Friedlaender, A; Metro, G; Signorelli, D; Gili, A; Economopoulou, P; Roila, F; Banna, G; De Toma, A; Camerini, A; Christopoulou, A; Lo Russo, G; Banini, M; Galetta, D; Jimenez, B; Collazo-Lorduy, A; Calles, A; Baxevanos, P; Linardou, H; Kosmidis, P; Mountzios, G; Garassino, MC; Addeo, A.

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score >= 50% treated with front-line pembrolizumab

Acta Oncologica. 2020; 59(9): 1058-1063 Nº de citas: 34 [doi:10.1080/0284186X.2020.1781249]

Van Cutsem, E; Danielewicz, I; Saunders, MP; Pfeiffer, P; Argiles, G; Borg, C; Glynne-Jones, R; Punt, CJA; Van de Wouw, AJ; Fedyanin, M; Stroyakovskiy, D; Kroening, H; Garcia-Alfonso, P; Wasan, H; Falcone, A; Kanehisa, A; Egorov, A; Aubel, P; Amellal, N; Moiseenko, V.

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

ANNALS OF ONCOLOGY. 2020; 31(9): 1160-1168 Nº de citas: 47 [doi:10.1016/j.annonc.2020.05.024]

Goetz, MP; Martin, M; Tokunaga, E; Park, IH; Huober, J; Toi, M; Stoffregen, C; Shekarriz, S; Andre, V; Gainford, MC; Price, GL; Johnston, S.

Health-RelatedQuality of Life inMONARCH3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy inHR+,HER2-Advanced Breast Cancer

ONCOLOGIST. 2020; 25(9): 1346-1354 Nº de citas: 43 [doi:10.1634/theoncologist.2020-0084]

Escudero-Vilaplana, V; Collado-Borrell, R; Hoyo-Munoz, A; Gimenez-Manzorro, A; Calles, A; Osorio, S; Herranz-Alonso, A; Sanjurjo-Saez, M.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

EXPERT OPINION ON DRUG SAFETY. 2020; 19(8): 1041-1048 Nº de citas: 9 [doi:10.1080/14740338.2020.1781089]

Vera, R; Gomez, ML; Ayuso, JR; Figueras, J; Garcia-Alfonso, P; Martinez, V; Lacasta, A; Ruiz-Casado, A; Safont, MJ; Aparicio, J; Campos, JM; Camara, JC; Martin-Richard, M; Montagut, C; Pericay, C; Vieitez, JM; Falco, E; Jorge, M; Marin, M; Salgado, M; Viudez, A.

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study

Cancers. 2020; 12(8): Nº de citas: 9 [doi:10.3390/cancers12082259]

Izquierdo, JAA; Lopez, IM; Morillo, PS; Rodas, IM; Cidoncha, EM.

Utility of PET/CT in patients with stage I-III melanoma

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(8): 1414-1417 Nº de citas: 8 [doi:10.1007/s12094-019-02252-2]

Camps Herrero, C; Batista, N; Diaz Fernandez, N; Escobar Alvarez, Y; Gonzalo Gomez, A; Isla Casado, D; Salud, A; Terrasa Pons, J; Guillem Porta, V.

Breakthrough cancer pain: review and calls to action to improve its management

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(8): 1216-1226 Nº de citas: 26 [doi:10.1007/s12094-019-02268-8]

Carmona-Bayonas, A; Gomez, D; de Castro, EM; Segura, PP; Langa, JM; Jimenez-Fonseca, P; Canovas, MS; Moran, LO; Escobar, IG; Blanco, ABR; Perez, IF; de Prado, PM; Balanya, RPI; Verduguez, TQ; Rodriguez-Lescure, A; Munoz, A.

A snapshot of cancer-associated thromboembolic disease in 2018-2019: First data from the TESEO prospective registry

EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2020; 78: 41-49 Nº de citas: 29 [doi:10.1016/j.ejim.2020.05.031]

Galeano-Valle, F; Perez-Rus, G; Demelo-Rodriguez, P; Ordieres-Ortega, L; Ortega-Moran, L; Munoz-Martin, AJ; Medina-Molina, S; Alvarez-Sala-Walther, LA; del-Toro-Cervera, J.

Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(8): 1312-1320 Nº de citas: 2 [doi:10.1007/s12094-019-02258-w]

Sanchis, AC; Gallego, J; Hernandez, R; Arrazubi, V; Custodio, A; Cano, JM; Aguado, G; Macias, I; Lopez, C; Lopez, F; Visa, L; Garrido, M; Lago, NM; Montes, AF; Limon, ML; Azkarate, A; Pimentel, P; Reguera, P; Ramchandani, A; Cacho, JD; Carnicero, AM; Granja, M; Richard, MM; Perez, CH; Hurtado, A; Serra, O; Buxo, E; Tocino, RV; Jimenez-Fonseca, P; Carmona-Bayonas, A.

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

PLoS One. 2020; 15(7): Nº de citas: 17 [doi:10.1371/journal.pone.0235848]

Amor-Garcia, MA; Collado-Borrell, R; Escudero-Vilaplana, V; Melgarejo-Ortuno, A; Herranz-Alonso, A; Arija, JAA; Sanjurjo-Saez, M.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis

JMIR mHealth and uHealth. 2020; 8(7): Nº de citas: 36 [doi:10.2196/17609]

Wainberg, ZA; Feeney, K; Lee, MA; Munoz, A; Gracian, AC; Lonardi, S; Ryoo, BY; Hung, AN; Lin, Y; Bendell, J; Hecht, JR.

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens

BMC CANCER. 2020; 20(1): Nº de citas: 23 [doi:10.1186/s12885-020-07110-x]

Onesti, CE; Rugo, HS; Generali, D; Peeters, M; Zaman, K; Wildiers, H; Harbeck, N; Martin, M; Cristofanilli, M; Cortes, J; Tjan-Heijnen, V; Hurvitz, SA; Berchem, G; Tagliamento, M; Campone, M; Bartsch, R; De Placido, S; Puglisi, F; Rottey, S; Muller, V; Ruhstaller, T; Machiels, JP; Conte, P; Awada, A; Jerusalem, G.

Oncological care organisation during COVID-19 outbreak

Esmo Open. 2020; 5(4): Nº de citas: 28 [doi:10.1136/esmoopen-2020-000853]

Segui, MA; Cruz, JJ; Alba, E; Feliu, J; Jara, C; Rivera, F; Lescure, AR; Lorenzo, A; Martin, M.

Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(7): 1049-1058 [doi:10.1007/s12094-019-02230-8]